Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.38 USD | +0.93% | -3.03% | +637.25% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+637.25% | 472M | |
+10.27% | 115B | |
+11.97% | 106B | |
-5.84% | 24.69B | |
-1.22% | 21.97B | |
-4.83% | 19.27B | |
-11.82% | 17.56B | |
-39.36% | 17.32B | |
+5.68% | 14.03B | |
+33.15% | 12.13B |
- Stock Market
- Equities
- CRBP Stock
- News Corbus Pharmaceuticals Holdings, Inc.
- Corbus Gets Exclusive Rights to Develop, Commercialize Clinical-Stage Nectin-4 Antibody Drug Conjugate CRB-701